Cite
Efficacy of Budesonide Foam in Patients with Mild-to-Moderate Ulcerative Colitis Treated with a Maximum Dose of Oral Mesalazine
MLA
Toshihide Ohmori. “Efficacy of Budesonide Foam in Patients with Mild-to-Moderate Ulcerative Colitis Treated with a Maximum Dose of Oral Mesalazine.” Nippon Daicho Komonbyo Gakkai Zasshi, vol. 74, Jan. 2021, pp. 153–61. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1696523fb527383a5c1ba73152abac09&authtype=sso&custid=ns315887.
APA
Toshihide Ohmori. (2021). Efficacy of Budesonide Foam in Patients with Mild-to-Moderate Ulcerative Colitis Treated with a Maximum Dose of Oral Mesalazine. Nippon Daicho Komonbyo Gakkai Zasshi, 74, 153–161.
Chicago
Toshihide Ohmori. 2021. “Efficacy of Budesonide Foam in Patients with Mild-to-Moderate Ulcerative Colitis Treated with a Maximum Dose of Oral Mesalazine.” Nippon Daicho Komonbyo Gakkai Zasshi 74 (January): 153–61. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1696523fb527383a5c1ba73152abac09&authtype=sso&custid=ns315887.